Showing 7981-7990 of 10904 results for "".
Verisante
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/verisante-/19449/News Reel on Vancouver, BC based Verisante discussing the company's partnership with BCCA (British Columbia Cancer Agency) to develop a new product for early skin cancer detection.Treating Plantar Warts with Low-Dose Microwave Technology
https://practicaldermatology.com/videos/c-suite-chats/treating-plantar-warts-with-low-dose-microwave-technology/67654/Emblation CEO Ian Stevens discusses how non-invasive microwave technology can improve dermatologists' treatment capabilities for plantar warts.Exploring Dupilumab's Impact on Growth in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/exploring-dupilumabs-impact-on-growth-in-pediatric-atopic-dermatitis/50962/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Michelle Tarbox, MD, FAAD, discuss emerging evidence and real-world experiences demonstrating how effective control of atopic dermatitis with dupilumab may support healthy growth and development in pediatric patieReducing Atopic March Risk in Pediatric Atopic Dermatitis
https://practicaldermatology.com/videos/type-ii-inflammation-journal-club/reducing-atopic-march-risk-in-pediatric-atopic-dermatitis/54821/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, is joined by Editorial Board member Peter Lio, MD, to analyze the Journal of the American Academy of Dermatology article "Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus cISDPA: Dr. Dy on JAK Inhibitors for Alopecia Areata
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-dy-jak-inhibitors-alopecia-areata/29150/Lady Dy, MD, talks about the efficacy and safety of JAK inhibitors for treating alopecia areata at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Expanding Access to Care Through a Virtual Platform
https://practicaldermatology.com/videos/c-suite-chats/expanding-access-to-care-through-a-virtual-platform/69071/Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer for Arcutis, discusses a new virtual health platform designed to expand access pathways to roflumilast for chronic inflammatory skin diseases.ISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-and-dr-zirwas-discuss-itchy-patient/27065/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks with Matthew Zirwas, MD, about Dr. Zirwas’s lecture on the itchy patient and the latest solutions for itch at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Practical Dermatology Roundtable: Reclaiming Urticaria, Ch. 1
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-1/84986/In the first installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD, discuss why chronic spontaneous urticaria care drifted toward allergy practices and how dermatologists can bring patients back with streamlined evaluation and ePractical Dermatology Roundtable: Reclaiming Urticaria, Ch. 2
https://practicaldermatology.com/programs/practical-dermatology/practical-dermatology-roundtable-reclaiming-urticaria-ch-2/84987/In the second installment of this five-part series, Brad P. Glick, DO, MPH, FAAD; Laura K. Ferris, MD, PhD; and Lawrence J. Green, MD, FAAD review key diagnostic clues that distinguish CSU from urticarial vasculitis and inducible urticaria, while addressing angioedema and practical treatment optionsNew Allergens Causing Contact Dermatitis
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/new-allergens-causing-contact-dermatitis/54644/Walter J. Liszewski, MD, discusses key takeaways from the “Contact Dermatitis Update 2026” session at Maui Derm Hawaii 2026.